Market Overview

8 Biggest Price Target Changes For Friday

Share:
  • Guggenheim cut Biogen Inc (NASDAQ: BIIB) price target from $410 to $325. Biogen shares closed at $321.17 on Thursday.
  • Berenberg cut the price target for Qualys Inc (NASDAQ: QLYS) from $96 to $82. Qualys shares closed at $84.34 on Thursday.
  • B. Riley FBR lifted the price target on Acacia Communications, Inc. (NASDAQ: ACIA) from $45 to $50.50. Acacia Communications shares closed at $47.17 on Thursday.
  • UBS cut the price target for Kraft Heinz Co (NASDAQ: KHC) from $55 to $39. Kraft Heinz shares closed at $48.18 on Thursday.
  • Guggenheim lowered the price target for Regeneron Pharmaceuticals Inc (NASDAQ: REGN) from $466 to $425. Regeneron Pharmaceuticals shares closed at $418.62 on Thursday.
  • RBC Capital lowered the price target for Immune Design Corp (NASDAQ: IMDZ) from $9 to $6. Immune Design shares closed at $5.82 on Thursday.
  • Jefferies raised Citigroup Inc (NYSE: C) price target from $64 to $73. Citigroup shares closed at $64.32 on Thursday.
  • Sidoti & Co. cut the price target for Anika Therapeutics Inc (NASDAQ: ANIK) from $56 to $41. Anika Therapeutics shares closed at $40.49 on Thursday.
 

Related Articles (ANIK + ACIA)

View Comments and Join the Discussion!

Posted-In: Price Target ChangesPrice Target Intraday Update Analyst Ratings

Latest Ratings

StockFirmActionPT
MRTXHC Wainwright & Co.Maintains257.0
NVDATruist SecuritiesMaintains672.0
NVDASusquehannaMaintains625.0
BLKBMO CapitalMaintains715.0
BLKDeutsche BankMaintains838.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com